European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact

Prostate cancer aggressiveness: A Central issue at the 22nd ESUR Meeting in Glasgow

Tue, 21 Oct 2014

Participants from leading European laboratories met at the ESUR Annual Meeting in Glasgow Grand Central Hotel from 9th to 11th October. Hot topics in several urological oncology areas have been presented by experienced researchers and talented young fellows. Focused lectures on stem cells and epithelial to mesenchymal transition were presented.

Gabri van der Pluijm (Leiden), Rakesh Heer (Newcastle), Paula Chiaruggi (Florence) and Giuseppina Carbone (Bellinzona) presented nice overviews on novel regulators of tumor stemness and progression. These regulators are miRNA and transcription factors. It is obvious that multiple miRNAs, either tumor promoting or tumor suppressive, regulate phenotypic changes of prostate cancer which are characterized by increased expression of mesenchymal markers.

Since it is clear that there are limitations of antiandrogen therapy, novel targets related to cellular stemness have been identified. Therefore, small molecules that target prostate cancer stemness are being developed. Hopefully, preclinical and clinical trials based on stem cell targeting may be a focus of future meetings of ESUR.

Research on aggressive prostate cancer by I. Ahmad (Beatson Institute of Cancer Research) in Pten mutant mice was awarded with the ARTP prize. Epithelial to mesenchymal transition has been addressed in several posters related to chemoresistance in carcinoma of the prostate. Some specific miRNA relevant to prostate cancer metastasis to bone has also been identified, such as miR-373.

This meeting was very useful in terms of building of new collaborations between leading European researchers, including preparations for the new European Union projects. Feedback from the participants was very positive and enthusiastic. Professor Hing Leung and the Board created a wonderful meeting environment and it is hope that the ESUR meeting will continue to grow in the next years.

Share this article

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer